171 related articles for article (PubMed ID: 25195370)
1. [Prostate health index in predicting the results of prostate biopsy for prostate cancer: a meta-analysis].
Liu Y; Xu Y; Zhang ZH; Yang K
Zhonghua Nan Ke Xue; 2014 Aug; 20(8):723-9. PubMed ID: 25195370
[TBL] [Abstract][Full Text] [Related]
2. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
Cui C; Sun X; Zhang J; Han D; Gu J
J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis.
Xue WJ; Ying XL; Jiang JH; Xu YH
J Cancer Res Ther; 2014 Nov; 10 Suppl():C218-21. PubMed ID: 25450286
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic accuracy of artery peak velocity variation measured by bedside real-time ultrasound for prediction of fluid responsiveness: a Meta-analysis].
Pei Y; Yang Y; Feng Y; He S; Zhou J; Jiang H; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):99-105. PubMed ID: 32148240
[TBL] [Abstract][Full Text] [Related]
5. Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.
Lazzeri M; Haese A; Abrate A; de la Taille A; Redorta JP; McNicholas T; Lughezzani G; Lista G; Larcher A; Bini V; Cestari A; Buffi N; Graefen M; Bosset O; Le Corvoisier P; Breda A; de la Torre P; Fowler L; Roux J; Guazzoni G
BJU Int; 2013 Aug; 112(3):313-21. PubMed ID: 23826841
[TBL] [Abstract][Full Text] [Related]
6. Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy.
Scattoni V; Lazzeri M; Lughezzani G; De Luca S; Passera R; Bollito E; Randone D; Abdollah F; Capitanio U; Larcher A; Lista G; Gadda GM; Bini V; Montorsi F; Guazzoni G
J Urol; 2013 Aug; 190(2):496-501. PubMed ID: 23466239
[TBL] [Abstract][Full Text] [Related]
7. PSAD Test in the Diagnosis of Prostate Cancer: a Meta-Analysis.
Feng ZJ; Xue C; Wen JM; Li Y; Wang M; Zhang N
Clin Lab; 2017 Jan; 63(1):147-155. PubMed ID: 28164507
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Detecting Residual or Recurrent Prostate Cancer After Radical Prostatectomy: A Pooled Analysis of 12 Individual Studies.
Yu T; Meng N; Chi D; Zhao Y; Wang Z; Luo Y
Cell Biochem Biophys; 2015 Jul; 72(3):687-94. PubMed ID: 27352188
[TBL] [Abstract][Full Text] [Related]
9. Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.
Perdonà S; Bruzzese D; Ferro M; Autorino R; Marino A; Mazzarella C; Perruolo G; Longo M; Spinelli R; Di Lorenzo G; Oliva A; De Sio M; Damiano R; Altieri V; Terracciano D
Prostate; 2013 Feb; 73(3):227-35. PubMed ID: 22821756
[TBL] [Abstract][Full Text] [Related]
10. Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.
Ferro M; Bruzzese D; Perdonà S; Mazzarella C; Marino A; Sorrentino A; Di Carlo A; Autorino R; Di Lorenzo G; Buonerba C; Altieri V; Mariano A; Macchia V; Terracciano D
Clin Chim Acta; 2012 Aug; 413(15-16):1274-8. PubMed ID: 22542564
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of serum macrophage inhibitory cytokine-1 in pancreatic cancer: a meta-analysis and meta-regression analysis.
Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
DNA Cell Biol; 2014 Jun; 33(6):370-7. PubMed ID: 24592997
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Urine Cytology in Bladder Cancer. A Meta-Analysis.
Xie Q; Huang Z; Zhu Z; Zheng X; Liu J; Zhang M; Zhang Y
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):38-44. PubMed ID: 27363065
[TBL] [Abstract][Full Text] [Related]
13. Assessment on clinical value of prostate health index in the diagnosis of prostate cancer.
Zhang G; Li Y; Li C; Li N; Li Z; Zhou Q
Cancer Med; 2019 Sep; 8(11):5089-5096. PubMed ID: 31313500
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis.
Guo R; Cai L; Fan Y; Jin J; Zhou L; Zhang K
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):221-8. PubMed ID: 25986915
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Prostate Health Index and 4-Kallikrein Panel Score in Predicting Overall and High-grade Prostate Cancer.
Russo GI; Regis F; Castelli T; Favilla V; Privitera S; Giardina R; Cimino S; Morgia G
Clin Genitourin Cancer; 2017 Aug; 15(4):429-439.e1. PubMed ID: 28111174
[TBL] [Abstract][Full Text] [Related]
16. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool.
Wang P; Guo YM; Liu M; Qiang YQ; Guo XJ; Zhang YL; Duan XY; Zhang QJ; Liang W
Korean J Radiol; 2008; 9(5):432-8. PubMed ID: 18838853
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of contrast enhanced ultrasound in patients with prostate cancer: a meta-analysis.
Li Y; Tang J; Fei X; Gao Y
Acad Radiol; 2013 Feb; 20(2):156-64. PubMed ID: 23103186
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis of diagnostic capability of frequency-doubling technology (FDT) for primary glaucoma].
Liu T; He XG
Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):403-8. PubMed ID: 16762233
[TBL] [Abstract][Full Text] [Related]
20. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
Marks LS; Fradet Y; Deras IL; Blase A; Mathis J; Aubin SM; Cancio AT; Desaulniers M; Ellis WJ; Rittenhouse H; Groskopf J
Urology; 2007 Mar; 69(3):532-5. PubMed ID: 17382159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
